- Orthofix Names Max Reinhardt President of Global Spine Business
- Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program
- Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail
- Orthofix Reports First Quarter 2024 Results
- Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
- Orthofix Names Andres Cedron as New Chief Legal Officer
- Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
- Orthofix Reports Fourth Quarter and Full Year 2023 Results
- Orthofix Announces New President for Bone Growth Therapies Business
More ▼
Key statistics
As of last trade, Orthofix Medical Inc (OFIX:NSQ) traded at 14.65, 53.00% above the 52 week low of 9.58 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.57 |
---|---|
High | 14.76 |
Low | 14.30 |
Bid | 14.64 |
Offer | 14.66 |
Previous close | 14.57 |
Average volume | 262.98k |
---|---|
Shares outstanding | 37.53m |
Free float | 35.89m |
P/E (TTM) | -- |
Market cap | 546.80m USD |
EPS (TTM) | -3.40 USD |
Data delayed at least 15 minutes, as of May 23 2024 16:15 BST.
More ▼